In order to provide novel insights into the AGEs-mediated signaling within the tumor microenvironment, we sought to address whether AGEs may also activate ERK1/2 and AKT in the CAFs obtained from breast tumor patients. This evidence concerns the gene MAPK3 and neoplasm.